Seres Therapeutics Company Insiders

Seres Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.3043) % which means that it has lost $0.3043 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.5628) %, meaning that it created substantial loss on money invested by shareholders. Seres Therapeutics' management efficiency ratios could be used to measure how well Seres Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At present, Seres Therapeutics' Return On Tangible Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0, whereas Return On Capital Employed is forecasted to decline to (1.29). At present, Seres Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 24.2 M, whereas Non Current Assets Total are forecasted to decline to about 63.1 M. The current year's Common Stock Shares Outstanding is expected to grow to about 163.2 M, whereas Net Loss is projected to grow to (213.9 M).

Seres Therapeutics Workforce Comparison

Seres Therapeutics Insider Trading

Seres Therapeutics Notable Stakeholders

The success or failure of an entity such as Seres Therapeutics often depends on how effective the management is. Seres Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Seres management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Seres management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Seres Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Seres Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Seres Therapeutics' management manipulating its earnings.

When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.